← All Stories
Market Data

Oura puts Nasdaq IPO on hold amid IPO market uncertainty

Oura has paused its planned Nasdaq IPO, citing uncertainty in the IPO market, after outlining a 50 million share offering at $40 to $44 per share.

Wooden letter blocks spelling IPO on a table, symbolizing investment opportunities.
Photo by Markus Winkler on Pexels

Oura is putting its initial public offering on the Nasdaq on hold, citing uncertainty in the IPO market, according to Dealbreaker. Oura and its early investors had planned to sell 50 million shares at $40 to $44 each, which would have raised about $2.1 billion at the midpoint and valued the company at roughly $15 billion, according to Dealbreaker.

IPO plans and targeted proceeds

Oura and its early investors had planned to sell 50 million shares at $40 to $44 each, according to Dealbreaker. Dealbreaker reported that the planned sale would have raised about $2.1 billion at the midpoint. Dealbreaker reported that the plan would have valued Oura at roughly $15 billion.

Rationale for the delay

Oura is putting its initial public offering on the Nasdaq on hold, according to Dealbreaker. Dealbreaker reported that Oura cited uncertainty in the IPO market as the reason for the pause. Dealbreaker reported that Oura said its business is continuing to grow despite the market uncertainty.

Reported operating metrics disclosed alongside the pause

Oura’s paid memberships have reached 5.7 million users, according to Dealbreaker. Dealbreaker reported that Oura expects revenue to grow 90% year-over-year in fiscal 2026.

Dealbreaker’s item referenced an “Oura Postpones Initial Public Offering” press release. Dealbreaker’s item also referenced “Oura Delays IPO Given Wall Street Jitters” from WWD.

As widely known context, IPOs are commonly postponed when issuers and underwriters assess that public-market conditions are not supportive of targeted pricing and valuation.

Sources
Topics
  • #oura
  • #ipo
  • #nasdaq
  • #consumer-health
  • #equity-capital-markets
Get capital raising signals before they hit the news.
Join Waitlist